Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase

Chemotherapy

Volumn 55, Issue 5, 2009, Pages 363-371

  Koshio, Osamu ^a   Ono, Yasuo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemiluminescence; Fluoroquinolone; fMLP; Grepafloxacin; p38 MAPK; Phosphorylation; Polymorphonuclear leukocytes; Reactive oxygen species; Signal transduction

Indexed keywords

ANTIBODY; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GREPAFLOXACIN; LUMINOL; MITOGEN ACTIVATED PROTEIN KINASE P38; PRULIFLOXACIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CHEMOLUMINESCENCE; CHEMOTAXIS; CONCENTRATION (PARAMETERS); DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; NEUTROPHIL; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DIOXOLANES; FLUOROQUINOLONES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PIPERAZINES; REACTIVE OXYGEN SPECIES;

EID: 68049109195     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232451     Document Type: Article

References (45)

1. Hirota M, Totsu T, Adachi F, Kamikawa K, Watanabe J, Kanegasaki S, Nakata K: Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages. J Infect Chemother 2001;7:16-21.
2. Imada T, Miyazaki S, Nishida M, Yamaguchi K, Goto S: In vitro and in vivo antimicrobial activities of a new quinolone, OPC-17116. Antimicrob Agents Chemother 1992;36:573-579.
3. Imada T, Goto S, Miyazaki S, Yamaguchi K, Kuwahara S: In vitro and in vivo antimicrobial effects of a new quinolone antimicrobial drug. Jpn J Chemother 1995;43:29-41.
4. Bailly S, Fay M, Ferrua B, Gougerot-Pocidalo MA: Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumor necrosis factor-α. Clin Exp Immunol 1991;85:331-334.
5. Bailly S, Fay M, Roche Y, Gougerot-Pocidalo MA: Effects of quinolones on tumor necrosis factor production by human monocytes. Int J Immunopharmacol 1990;12:31-36. (Pubitemid 20034208)
6. Bailly S, Mahe Y, Ferrua B, Fay M, Tursz T, Wakasugi H, Gougerot-Pocidalo MA: Quinolone-induced differential modulation of IL-1α and IL-1β production by LPS-stimulated human monocytes. Cell Immunol 1990;128:277-288. (Pubitemid 20225569)
7. Roche Y, Fay M, Gougerot-Pocidalo MA: Effects of quinolones on interleukin 1 production in vitro by human monocytes. Immunopharmacology 1987;13:99-109. (Pubitemid 17052432)
8. Roche Y, Gougerot-Pocidalo MA, Fay M, Etienne D, Forest N, Pocidalo JJ: Comparative effects of quinolones on human mononuclear leukocyte functions. J Antimicrob Chemother 1987;19:781-790. (Pubitemid 17092064)
9. Hara T, Takemura H, Kanemitsu K, Yamamoto H, Shimada J: Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1. J Infect Chemother 2000;6:162-167. (Pubitemid 30797388)
10. Khan AA, Slifer TR, Araujo FG, Suzuki Y, Remington JS: Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob Agents Chemother 2000;44:3169-3173. (Pubitemid 30803087)
11. Khan AA, Slifer TR, Remington JS: Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob Agents Chemother 1998;42:1713-1717. (Pubitemid 28311567)
12. Hotta K, Niwa M, Hirota M, Kanamori Y, Matsuno H, Kozawa O, Otsuka T, Matsui N, Uematsu T: Regulation of fluoroquinolone uptake by human neutrophils: involvement of mitogen-activated protein kinase. J Antimicrob Chemother 2002;49:953-959. (Pubitemid 34692889)
13. Tullio V, Cuffini AM, Bonino A, Ianni Palarchio A, Roana J, Mandras N, Rossi V, Carlone NA: Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin), on macrophage functions against Klebsiella pneuminiae: an in vitro comparison with pefloxacin. J Antimicrob Chemother 2000;46:241-247.
14. Yagi Y, Aoki M, Iguchi M, Shibasaki S, Kurosawa T, Kato Y, Tsuji A: Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats. Drug Metab Pharmacokinet 2007;22:350-357.
15. Matera MG: Review: Pharmacologic characteristics of prulifloxacin. Pulm Pharmacol Ther 2006;19:20-29.
16. Yamamori T, Inanami O, Nagahata H, Cui Y-D, Kuwabara M: Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes. FEBS Lett 2000;467:253-258.
17. - production in neutrophils. Free Radic Biol Med 2004;36:1259-1269.
18. Brown GE, Stewart MQ, Bissonnette SA, Elia AEH, Wilker E, Yaffe MB: Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase. J Biol Chem 2004;279:27059-27068. (Pubitemid 38812542)
19. Ashida N, Arai H, Yamasaki M, Kita T: Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J Biol Chem 2001;276:16555-16560. (Pubitemid 37391707)
20. Niwa M, Kanamori Y, Hotta K, Matsuno H, Kozawa O, Fujimoto S, Uematsu T: Priming by grepafloxacin on respiratory burst of human neutrophils: its possible mechanism. J Antimicrob Chemother 2002;50:469-478. (Pubitemid 35214785)
21. Maeda T, Takahashi K, Ohtsu N, Oguma T, Ohnishi T, Atsumi R, Tamai I: Identification of influx transporter for the quinolone antibacterial agent levofloxacin. Mol Pharm 2007;4:85-94. (Pubitemid 46302131)
22. phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol 2001;166:1206-1213.
23. phox phosphorylation and translocation in activated human monocytes. J Immunol 2004;173:5730-5738.
24. phox by controlling cPKC/PKCδ but not Akt. Biochem Biophys Res Commun 2004;316:720-730.
25. phox and mediates respiratory burst activity in human neutrophils. J Immunol 2003;170:5302-5308.
26. PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc Natl Acad Sci USA 2003;100:5130-5135.
27. Yan SR, Al-Hertani W, Byers D, Bortolussi R: Lipopolysaccharide-binding protein- and CD14-dependent activation of mitogen-activated protein kinase p38 by lipopolysaccharide in human neutrophils is associated with priming of respiratory burst. Infect Immun 2002;70:4068-4074. (Pubitemid 34790914)
28. Lal AS, Clifton AD, Rouse J, Segal AW, Cohen P: Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38. Biochem Biophys Res Commun 1999;259:465-470. (Pubitemid 29281254)
29. Cook PJ, Andrews JM, Wise R, Honeybourne D, Moudgil H: Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments. J Antimicrob Chemother 1995;35:317-326.
30. Sasabe H, Kato Y, Suzuki T, Itose M, Miyamoto G, Sugiyama Y: Carrier-mediated uptake of grepafloxacin, a fluoroquinolone antibiotic, by the isolated rat lung cells. Drug Metab Pharmacokinet 2005;20:491-495.
31. Ito T, Yano I, Masuda S, Hashimoto Y, Inui K: Distribution characteristics of levofloxacin and grepafloxacin in rat kidney. Pharmacol Res 1999;16:534-539. (Pubitemid 29191298)
32. Deguchi Y, Sun J, Tauchi Y, Sakai S, Morimoto K: Distribution characteristics of grepafloxacin, a fluoroquinolone antibiotic, in lung epithelial lining fluid and alveolar macrophage. Drug Metab Pharmacokinet 2003;18:319-326.
33. Taira K, Koga H, Kohno S: Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1993;37:1877-1881. (Pubitemid 23265546)
34. Maeda T, Takahashi K, Ohtsu N, Oguma T, Ohnishi T, Atsumi R, Tamai I: Identification of influx transporter for the quinolone antibacterial agent levofloxacin. Mol Pharm 2007;4:85-94. (Pubitemid 46302131)
35. Tirona RG, Kim RB: Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv Drug Deliv Rev 2002;54:1343-1352.
36. Fàbrega A, Madurga S, Giralt E, Vila J: Mechanism of action of and resistance to quinolones. Microb Biotechnol 2009;2:40-61.
37. Escribano I, Rodríguez JC, Llorca B, García-Pachon E, Ruiz M, Royo G: Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 2007;53:397-401.
38. Horii T, Osaki M, Muramatsu H: Fluoroquinolone resistance in clinical isolates of Klebsiella oxytoca. Chemotherapy 2008;54:323-327.
39. Lee CC, Lee VWY, Chan FKL, Ling TKW: Levofloxacin-resistant Helicobacter pylori in Hong Kong. Chemotherapy 2008;54:50-53.
40. Jog NR, Jala VR, Ward RA, Rane MJ, Haribabu B, McLeish KR: Heat shock protein 27 regulates neutrophil chemotaxis and exocytosis through two independent mechanisms. J Immunol 2007;178:2421-2428. (Pubitemid 46233442)
41. phox of neutrophil NADPH oxidase. Biochem Biophys Res Commun 2000;276:1186-1190.
42. Huang C-K, Zhan L, Ai Y, Jongstra J: LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J Biol Chem 1997;272:17-19. (Pubitemid 27021115)
43. Wu Y, Zhan L, Ai Y, Hannigan M, Gaestel M, Huang C-K, Madri JA: MAPKAPK2-mediated LSP1 phosphorylation and FMLP-induced neutrophil polarization. Biochem Biophys Res Comm 2007;358:170-175. (Pubitemid 46719098)
44. Wu Y, Hannigan MO, Kotlyarov A, Gaestel M, Wu D, Huang C-K: A requirement of MAPKAPK2 in the uropod localization of PTEN during FMLP-induced neutrophil chemotaxis. Biochem Biophys Res Commun 2004;316:666-672. (Pubitemid 38368004)
45. Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, Miller BJ, Jirik FR, Kubes P: PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat Immunol 2008;9:743-752.